Abstract 81P
Background
Single-cell technologies have revealed novel insights about the complexity of the tumor immune microenvironment. Most clinical strategies rely on histopathological stratification of tumor subtypes, yet the spatial context of cellular interactions within these stratified subgroups remains poorly understood. We previously applied imaging mass cytometry, a novel technology, to describe the tumor and immunological landscape of lung adenocarcinoma (LUAD) patient tumors across five histological subtypes of lung adenocarcinoma. We resolved over 1 million cells, enabling an understanding of the cellular spatial relationships associated with distinct clinical correlates, such as survival. Here, we compare the immune landscape of LUAD with lung squamous cell carcinoma (LUSC), a different subtype of lung cancer.
Methods
Imaging mass cytometry (IMC) is a novel technology which allows for the use of up to 50 antibodies labelled with metal isotopes to characterize the tumour and the tumour immune microenvironment. Our research group has optimized a panel of IMC markers delineating immune, tumour and structural cell types. Using IMC we have assessed the frequency of 16 different cell types, the interactions across these cells and their organization into cellular communities. We have compared these outputs across LUAD and LUSC patients.
Results
We show that LUAD and LUSC exhibit distinct immune profiles. Lung squamous cell carcinoma is characterized by a higher prevalence of neutrophils and a lower prevalence of macrophages compared to LUAD. In addition, our spatial analysis of immune lineages demonstrates contrasting cellular interactions across LUAD and LUSC as well as unique arrangements of immune cells into cellular neighborhoods. This highlights the spatial heterogeneity that exists across lung cancer subtypes beyond the prevalence of immune cell types alone.
Conclusions
Our results describe the importance of spatial interactions by demonstrating how distinct spatial profiles can exist across subtypes of lung cancer. Overall, we find unique immune profiles across LUAD and LUSC as it relates to immune frequencies, pairwise cellular interactions and communities of cells.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Rosalind and Morris Goodman Chair in Lung Cancer Research.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
104P - Hypomethylated immune gene promoters as potential biomarkers in oral and oropharyngeal cancer
Presenter: Petra Anić
Session: Cocktail & Poster Display session
Resources:
Abstract
105P - Implementation of technical improvements in cfMeDIP-Seq library preparation
Presenter: Martina Dameri
Session: Cocktail & Poster Display session
Resources:
Abstract
106P - Clinical application of next-generation sequencing in metastatic colorectal cancer (mCRC): Experience from a comprehensive cancer centre
Presenter: David Lluís Garulo
Session: Cocktail & Poster Display session
Resources:
Abstract
107P - Unveiling mismatch repair deficiency (dMMR) and microsatellite-instability high (MSI-H) detection in cancer patients (pt) using a next-generation sequencing (NGS)-based molecular pre-screening program (MPP)
Presenter: Lucia Notario Rincon
Session: Cocktail & Poster Display session
Resources:
Abstract
108P - Validation and implementation of a large NGS panel to test liquid biopsies from patients with suspected advanced non-small cell lung cancer (NSCLC) in an NHS genomic laboratory for the QuicDNA biomarker study
Presenter: Rachel Dodds
Session: Cocktail & Poster Display session
Resources:
Abstract
109P - A multiomic, single-cell measurable residual disease (scMRD) assay for phasing DNA mutations and surface immunophenotypes
Presenter: Simone Formisano
Session: Cocktail & Poster Display session
Resources:
Abstract
110P - Multicellular three-dimensional tumor spheroid of nasopharyngeal carcinoma
Presenter: Shiau Chuen Cheah
Session: Cocktail & Poster Display session
Resources:
Abstract
111P - Development of digital PCR for accurate measurement of HER2 amplification in 184 gastric cancer patients
Presenter: So Young Kang
Session: Cocktail & Poster Display session
Resources:
Abstract
112P - A novel methylation-sensitive assay for early detection of hepatocellular carcinoma to improve surveillance
Presenter: Jeong Sil Ha
Session: Cocktail & Poster Display session
Resources:
Abstract
113P - Evaluation of effects of tissue preservation methods on the proteome abundance through deep proteomics of breast cancer tissue
Presenter: Shashwati parihari
Session: Cocktail & Poster Display session
Resources:
Abstract